Abstract | BACKGROUND: A new fractional photothermolysis device is used in our retrospective study to treat melasma in Chinese patients. OBJECTIVES: To evaluate the efficacy and safety of the 1927 nm fractional thulium fiber laser in the treatment of melasma in Chinese patients. METHODS: Eleven melasma patients who received treatment between November 2009 and May 2010 were included. Photographic images at baseline and follow-up were assessed for clinical efficacy and complications by two independent and blinded physicians. Questionnaires were also completed by patients. RESULTS: Significant MASI improvements were seen at 1 week, 1 month and 2 months, but not at 3 months. Patients' degree of satisfaction was high. Significant improvement in skin texture and pore size was seen for up to 2 months and improvement in wrinkles for up to a month. There was no change in skin laxity. Main adverse effects seen were erythema, edema, and crusting in the early days. One patient developed PIH. CONCLUSION: The novel 1927 nm fractional thulium fiber laser is safe and effective in the management of melasma in Chinese patients for up to 2 months. It is also useful in photo- rejuvenation. Complications were limited to erythema and edema in the early days, and transient PIH.
|
Authors | Stephanie G Y Ho, C K Yeung, Nicola P Y Chan, Samantha Y Shek, Henry H L Chan |
Journal | Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
(J Cosmet Laser Ther)
Vol. 15
Issue 4
Pg. 200-6
(Aug 2013)
ISSN: 1476-4180 [Electronic] England |
PMID | 23384107
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Edema
(etiology)
- Erythema
(etiology)
- Female
- Humans
- Hyperpigmentation
(etiology)
- Lasers, Solid-State
(therapeutic use)
- Melanosis
(surgery)
- Middle Aged
- Patient Satisfaction
- Purpura
(etiology)
- Retrospective Studies
- Skin Aging
- Thulium
|